ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 37 filers reported holding ENOCHIAN BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9 | +50.0% | 9,819 | +85.0% | 0.00% | – |
| Q4 2022 | $6 | -99.7% | 5,307 | +533.3% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 838 | -15.4% | 0.00% | – |
| Q2 2022 | $2,000 | -90.0% | 991 | -74.6% | 0.00% | – |
| Q2 2021 | $20,000 | -72.2% | 3,908 | -80.9% | 0.00% | – |
| Q1 2021 | $72,000 | +84.6% | 20,480 | +52.8% | 0.00% | – |
| Q4 2020 | $39,000 | +69.6% | 13,401 | +112.1% | 0.00% | – |
| Q3 2020 | $23,000 | -30.3% | 6,319 | -17.9% | 0.00% | – |
| Q2 2020 | $33,000 | +135.7% | 7,696 | +68.2% | 0.00% | – |
| Q1 2020 | $14,000 | -79.7% | 4,576 | -66.8% | 0.00% | – |
| Q4 2019 | $69,000 | +527.3% | 13,776 | +596.1% | 0.00% | – |
| Q3 2019 | $11,000 | -8.3% | 1,979 | -23.6% | 0.00% | – |
| Q2 2019 | $12,000 | +50.0% | 2,589 | +116.3% | 0.00% | – |
| Q1 2019 | $8,000 | – | 1,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |